PL2021794T3 - Zastosowanie białka S100A 12 jako markera raka okrężnicy i odbytnicy - Google Patents
Zastosowanie białka S100A 12 jako markera raka okrężnicy i odbytnicyInfo
- Publication number
- PL2021794T3 PL2021794T3 PL07725293T PL07725293T PL2021794T3 PL 2021794 T3 PL2021794 T3 PL 2021794T3 PL 07725293 T PL07725293 T PL 07725293T PL 07725293 T PL07725293 T PL 07725293T PL 2021794 T3 PL2021794 T3 PL 2021794T3
- Authority
- PL
- Poland
- Prior art keywords
- colorectal cancer
- protein
- marker
- diagnosis
- relates
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4727—Calcium binding proteins, e.g. calmodulin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/795—Porphyrin- or corrin-ring-containing peptides
- G01N2333/805—Haemoglobins; Myoglobins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
- G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- G01N2333/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06010439 | 2006-05-19 | ||
| PCT/EP2007/004378 WO2007134779A1 (en) | 2006-05-19 | 2007-05-16 | Use of protein s100a 12 as a marker for colorectal cancer |
| EP07725293A EP2021794B8 (en) | 2006-05-19 | 2007-05-16 | Use of protein s100a 12 as a marker for colorectal cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2021794T3 true PL2021794T3 (pl) | 2010-12-31 |
Family
ID=37087565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL07725293T PL2021794T3 (pl) | 2006-05-19 | 2007-05-16 | Zastosowanie białka S100A 12 jako markera raka okrężnicy i odbytnicy |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20090286328A1 (enExample) |
| EP (1) | EP2021794B8 (enExample) |
| JP (1) | JP4942813B2 (enExample) |
| KR (1) | KR101147586B1 (enExample) |
| CN (1) | CN101449163B (enExample) |
| AT (1) | ATE471512T1 (enExample) |
| AU (1) | AU2007251933B2 (enExample) |
| BR (1) | BRPI0711763A2 (enExample) |
| CA (1) | CA2651709A1 (enExample) |
| DE (1) | DE602007007209D1 (enExample) |
| DK (1) | DK2021794T3 (enExample) |
| ES (1) | ES2347485T3 (enExample) |
| MX (1) | MX2008014482A (enExample) |
| PL (1) | PL2021794T3 (enExample) |
| WO (1) | WO2007134779A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10957217B2 (en) | 2006-08-25 | 2021-03-23 | Ronald A. Weitzman | Population-sample regression in the estimation of population proportions |
| US11151895B2 (en) * | 2006-08-25 | 2021-10-19 | Ronald Weitzman | Population-sample regression in the estimation of population proportions |
| ATE521894T1 (de) * | 2007-11-20 | 2011-09-15 | Hoffmann La Roche | Verfahren zur beurteilung von kolorektalem krebs anhand einer stuhlprobe durch verwendung einer marker-kombination aus calprotectin und einem hämoglobin/haptoglobin-komplex |
| US9089540B2 (en) * | 2008-01-31 | 2015-07-28 | Keio University | Method for determination of sensitivity to anti-cancer agent |
| EP2255198A4 (en) * | 2008-02-15 | 2011-05-25 | Mayo Foundation | DETECTION OF NEOPLASM |
| WO2015067913A1 (en) | 2013-11-07 | 2015-05-14 | Diagnodus Limited | Biomarkers |
| CN103033623A (zh) * | 2012-12-10 | 2013-04-10 | 天津市协和医药科技集团有限公司 | 人m2型丙酮酸激酶化学发光免疫分析试剂盒及制备方法 |
| CN104178562B (zh) * | 2013-05-21 | 2018-11-09 | 生物梅里埃股份公司 | 一种大肠癌预后试剂盒 |
| US10184154B2 (en) | 2014-09-26 | 2019-01-22 | Mayo Foundation For Medical Education And Research | Detecting cholangiocarcinoma |
| EP3274440A4 (en) | 2015-03-27 | 2019-03-06 | Exact Sciences Corporation | Detecting esophageal disorders |
| CN107271681A (zh) * | 2017-06-05 | 2017-10-20 | 中国人民解放军沈阳军区总医院 | 血浆s100a12在st段抬高型心肌梗死早期诊断中的应用 |
| CA3096391A1 (en) * | 2018-04-12 | 2019-10-17 | Board Of Regents, The University Of Texas System | Biomarker for detecting cancer |
| EP4004549A1 (en) * | 2019-07-23 | 2022-06-01 | Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis | Progression markers for colorectal adenomas |
| JP7741067B2 (ja) * | 2019-10-18 | 2025-09-17 | エグザクト サイエンシーズ コーポレーション | 複数の分析物を用いた糞便抗原検査 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61137064A (ja) * | 1984-12-07 | 1986-06-24 | Fujirebio Inc | 大腸癌の予備スクリ−ニング方法 |
| DE3838900A1 (de) * | 1988-11-17 | 1990-05-23 | Scheefers Borchel Ursula | Pyruvatkinase-isoenzym typ m2 (tumor m2-pk) spezifische antikoerper/verfahren zu deren herstellung und deren verwendung |
| JPH02193071A (ja) * | 1989-01-20 | 1990-07-30 | Green Cross Corp:The | ハプトグロビン―ヘモグロビン複合体測定用試薬キット及びそれを用いるハプトグロビン―ヘモグロビン複合体の測定法 |
| JPH08238090A (ja) * | 1995-03-06 | 1996-09-17 | Jiro Hitomi | 新規カルシウム結合タンパク |
| US20030175713A1 (en) * | 2002-02-15 | 2003-09-18 | Clemens Sorg | Method for diagnosis of inflammatory diseases using CALGRANULIN C |
| JP2004198419A (ja) * | 2002-12-13 | 2004-07-15 | Bayer Healthcare Llc | Ｔｉｍｐ１を用いた検出方法 |
| EP1601969A2 (en) * | 2003-03-08 | 2005-12-07 | Auvation Ltd | Markers for colorectal cancer |
| WO2005054508A2 (en) * | 2003-12-01 | 2005-06-16 | Ipsogen | Gene expression profiling of colon cancer by dna microarrays and correlation with survival and histoclinical parameters |
| TR200700896T1 (tr) * | 2004-07-23 | 2007-04-24 | Aspenbio, Inc. | Apandisit teşhisine ilişkin yöntem ve cihazlar |
-
2007
- 2007-05-16 CN CN200780018059.1A patent/CN101449163B/zh not_active Expired - Fee Related
- 2007-05-16 EP EP07725293A patent/EP2021794B8/en not_active Not-in-force
- 2007-05-16 WO PCT/EP2007/004378 patent/WO2007134779A1/en not_active Ceased
- 2007-05-16 DK DK07725293.0T patent/DK2021794T3/da active
- 2007-05-16 DE DE602007007209T patent/DE602007007209D1/de active Active
- 2007-05-16 AU AU2007251933A patent/AU2007251933B2/en not_active Ceased
- 2007-05-16 KR KR1020087028063A patent/KR101147586B1/ko not_active Expired - Fee Related
- 2007-05-16 ES ES07725293T patent/ES2347485T3/es active Active
- 2007-05-16 AT AT07725293T patent/ATE471512T1/de active
- 2007-05-16 CA CA002651709A patent/CA2651709A1/en not_active Abandoned
- 2007-05-16 MX MX2008014482A patent/MX2008014482A/es active IP Right Grant
- 2007-05-16 BR BRPI0711763-9A patent/BRPI0711763A2/pt active Search and Examination
- 2007-05-16 PL PL07725293T patent/PL2021794T3/pl unknown
- 2007-05-16 JP JP2009510351A patent/JP4942813B2/ja not_active Expired - Fee Related
-
2008
- 2008-11-04 US US12/264,324 patent/US20090286328A1/en not_active Abandoned
-
2014
- 2014-08-20 US US14/463,975 patent/US20150192587A1/en not_active Abandoned
-
2017
- 2017-01-06 US US15/399,801 patent/US20170115294A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007134779A1 (en) | 2007-11-29 |
| US20170115294A1 (en) | 2017-04-27 |
| JP4942813B2 (ja) | 2012-05-30 |
| DK2021794T3 (da) | 2010-10-11 |
| EP2021794B8 (en) | 2010-08-18 |
| ES2347485T3 (es) | 2010-10-29 |
| ATE471512T1 (de) | 2010-07-15 |
| AU2007251933A1 (en) | 2007-11-29 |
| CN101449163A (zh) | 2009-06-03 |
| KR101147586B1 (ko) | 2012-08-23 |
| CN101449163B (zh) | 2014-06-25 |
| CA2651709A1 (en) | 2007-11-29 |
| MX2008014482A (es) | 2008-11-27 |
| BRPI0711763A2 (pt) | 2011-12-06 |
| JP2009537798A (ja) | 2009-10-29 |
| US20150192587A1 (en) | 2015-07-09 |
| EP2021794A1 (en) | 2009-02-11 |
| DE602007007209D1 (de) | 2010-07-29 |
| EP2021794B1 (en) | 2010-06-16 |
| HK1133295A1 (en) | 2010-03-19 |
| KR20090007454A (ko) | 2009-01-16 |
| US20090286328A1 (en) | 2009-11-19 |
| AU2007251933B2 (en) | 2011-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2021794T3 (pl) | Zastosowanie białka S100A 12 jako markera raka okrężnicy i odbytnicy | |
| ATE554389T1 (de) | Apex als marker für lungenkrebs | |
| EP2321430B8 (en) | Method of evaluating oral cancer risk in human | |
| KR100711046B1 (ko) | 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도 | |
| MX2010005893A (es) | Marcadores de expresion genica para enfermedad inflamatoria de intestino. | |
| WO2008021290A8 (en) | Organ-specific proteins and methods of their use | |
| PH12018550037A1 (en) | Quencher containing water-soluble polymer-conjugated nanomaterial and use thereof | |
| EP2584049A3 (en) | Gene expression markers for Crohn's disease | |
| WO2007114986A3 (en) | Cooperative probes and methods of using them | |
| EP2075341A4 (en) | METHOD FOR THE INVESTIGATION, DETERMINATION OR EVALUATION BY MEANS OF GENE EXPRESSION ANALYSIS | |
| WO2010046648A3 (en) | Diagnostic test for streptococcus equi | |
| WO2005124356A3 (en) | Use of protein cbp2 as a marker for colorectal cancer | |
| WO2008153543A3 (en) | Fluorescent mouse model | |
| WO2008131261A3 (en) | Peptide biomarkers of cardiovascular disease | |
| ATE468535T1 (de) | Verwendung von nnmt als marker für lungenkrebs | |
| ATE503846T1 (de) | Verfahren zur diagnose eines ovarialkarzinoms | |
| WO2010000467A8 (en) | Asc as a marker for lung cancer | |
| DE602004017317D1 (de) | Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome | |
| WO2005040806A3 (en) | Use of protein asc as a marker for breast cancer | |
| MX341181B (es) | Metodo para someter a prueba a un sujeto que se cree esta predispuesto a tener cancer metastasico usando delta133p53beta. | |
| WO2008090177A3 (en) | Diagnosis of prostate cancer | |
| DE602004001994D1 (de) | Verwendung des proteins masp als marker für kolorektale karzinome | |
| WO2009019366A3 (fr) | Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal | |
| WO2013165969A3 (en) | Methods and kits for diagnosing heparin-induced thrombocytopenia | |
| WO2004071267A3 (en) | Diagnosis of colorectal cancer by detection of nicotinamide n-methyltransferase in a stool sample |